Siren, L.L.C.

Siren, L.L.C. insider trades: Lexicon Pharmaceuticals (LXRX) stock buys and sales

Lexicon Pharmaceuticals Last trade Feb 2, 2026 8 Form 4 filings
$0
Sold, last 12 months
0 sales
$2.0M
Bought, last 12 months
1 buy
7
Open-market trades
since 2024
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Siren, L.L.C. reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 2, 2026LXRX↑ Buy$2.0M
Dec 10, 2024SRRK↓ Sell$66.6M
Nov 25, 2024SRRK↓ Sell$15.8M
Aug 8, 2024GLYC↓ Sell$61K
Aug 6, 2024GLYC↓ Sell$41K
Aug 2, 2024GLYC↓ Sell$71K
Jul 30, 2024GLYC↓ Sell$315K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other LXRX insiders

Open-market trades in the last 12 months

About Siren, L.L.C.'s insider trades

Siren, L.L.C. is an insider at Lexicon Pharmaceuticals (LXRX). Since Jul 30, 2024, it has reported 1 open-market purchase worth $2.0M and 6 sales worth $82.9M on SEC Form 4. In the last 12 months: 1 buy ($2.0M).

Its filings also include grants and awards (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LXRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.